Device Closure of a Large Atrial Septal Defect in a Patient with Severe Pulmonary Arterial Hypertension after 1 Year Use of an Oral Endothelin Receptor Antagonist

The presence of severe pulmonary arterial hypertension (PAH) in patients with atrial septal defect (ASD) is still thought to preclude shunt closure, although there are several reports of good clinical outcomes after vasodilator therapy. We report the case of a young woman with ASD and severe PAH who...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, In Hyun, Lee, Sang Yun, Lee, Sook Jin, Lee, Joo Young, Park, Nam Jin, Ahn, Dea Sung, Jung, Jae Hoon, Shin, Dong Hee, Lim, Dal Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Echocardiography 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816165/
https://www.ncbi.nlm.nih.gov/pubmed/24198921
http://dx.doi.org/10.4250/jcu.2013.21.3.140
_version_ 1782289500892823552
author Jung, In Hyun
Lee, Sang Yun
Lee, Sook Jin
Lee, Joo Young
Park, Nam Jin
Ahn, Dea Sung
Jung, Jae Hoon
Shin, Dong Hee
Lim, Dal Soo
author_facet Jung, In Hyun
Lee, Sang Yun
Lee, Sook Jin
Lee, Joo Young
Park, Nam Jin
Ahn, Dea Sung
Jung, Jae Hoon
Shin, Dong Hee
Lim, Dal Soo
author_sort Jung, In Hyun
collection PubMed
description The presence of severe pulmonary arterial hypertension (PAH) in patients with atrial septal defect (ASD) is still thought to preclude shunt closure, although there are several reports of good clinical outcomes after vasodilator therapy. We report the case of a young woman with ASD and severe PAH who was able to successfully undergo percutaneous shunt closure following 1 year use of the oral endothelin receptor antagonist, bosentan.
format Online
Article
Text
id pubmed-3816165
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Korean Society of Echocardiography
record_format MEDLINE/PubMed
spelling pubmed-38161652013-11-06 Device Closure of a Large Atrial Septal Defect in a Patient with Severe Pulmonary Arterial Hypertension after 1 Year Use of an Oral Endothelin Receptor Antagonist Jung, In Hyun Lee, Sang Yun Lee, Sook Jin Lee, Joo Young Park, Nam Jin Ahn, Dea Sung Jung, Jae Hoon Shin, Dong Hee Lim, Dal Soo J Cardiovasc Ultrasound Case Report The presence of severe pulmonary arterial hypertension (PAH) in patients with atrial septal defect (ASD) is still thought to preclude shunt closure, although there are several reports of good clinical outcomes after vasodilator therapy. We report the case of a young woman with ASD and severe PAH who was able to successfully undergo percutaneous shunt closure following 1 year use of the oral endothelin receptor antagonist, bosentan. Korean Society of Echocardiography 2013-09 2013-09-30 /pmc/articles/PMC3816165/ /pubmed/24198921 http://dx.doi.org/10.4250/jcu.2013.21.3.140 Text en Copyright © 2013 Korean Society of Echocardiography http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Jung, In Hyun
Lee, Sang Yun
Lee, Sook Jin
Lee, Joo Young
Park, Nam Jin
Ahn, Dea Sung
Jung, Jae Hoon
Shin, Dong Hee
Lim, Dal Soo
Device Closure of a Large Atrial Septal Defect in a Patient with Severe Pulmonary Arterial Hypertension after 1 Year Use of an Oral Endothelin Receptor Antagonist
title Device Closure of a Large Atrial Septal Defect in a Patient with Severe Pulmonary Arterial Hypertension after 1 Year Use of an Oral Endothelin Receptor Antagonist
title_full Device Closure of a Large Atrial Septal Defect in a Patient with Severe Pulmonary Arterial Hypertension after 1 Year Use of an Oral Endothelin Receptor Antagonist
title_fullStr Device Closure of a Large Atrial Septal Defect in a Patient with Severe Pulmonary Arterial Hypertension after 1 Year Use of an Oral Endothelin Receptor Antagonist
title_full_unstemmed Device Closure of a Large Atrial Septal Defect in a Patient with Severe Pulmonary Arterial Hypertension after 1 Year Use of an Oral Endothelin Receptor Antagonist
title_short Device Closure of a Large Atrial Septal Defect in a Patient with Severe Pulmonary Arterial Hypertension after 1 Year Use of an Oral Endothelin Receptor Antagonist
title_sort device closure of a large atrial septal defect in a patient with severe pulmonary arterial hypertension after 1 year use of an oral endothelin receptor antagonist
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816165/
https://www.ncbi.nlm.nih.gov/pubmed/24198921
http://dx.doi.org/10.4250/jcu.2013.21.3.140
work_keys_str_mv AT junginhyun deviceclosureofalargeatrialseptaldefectinapatientwithseverepulmonaryarterialhypertensionafter1yearuseofanoralendothelinreceptorantagonist
AT leesangyun deviceclosureofalargeatrialseptaldefectinapatientwithseverepulmonaryarterialhypertensionafter1yearuseofanoralendothelinreceptorantagonist
AT leesookjin deviceclosureofalargeatrialseptaldefectinapatientwithseverepulmonaryarterialhypertensionafter1yearuseofanoralendothelinreceptorantagonist
AT leejooyoung deviceclosureofalargeatrialseptaldefectinapatientwithseverepulmonaryarterialhypertensionafter1yearuseofanoralendothelinreceptorantagonist
AT parknamjin deviceclosureofalargeatrialseptaldefectinapatientwithseverepulmonaryarterialhypertensionafter1yearuseofanoralendothelinreceptorantagonist
AT ahndeasung deviceclosureofalargeatrialseptaldefectinapatientwithseverepulmonaryarterialhypertensionafter1yearuseofanoralendothelinreceptorantagonist
AT jungjaehoon deviceclosureofalargeatrialseptaldefectinapatientwithseverepulmonaryarterialhypertensionafter1yearuseofanoralendothelinreceptorantagonist
AT shindonghee deviceclosureofalargeatrialseptaldefectinapatientwithseverepulmonaryarterialhypertensionafter1yearuseofanoralendothelinreceptorantagonist
AT limdalsoo deviceclosureofalargeatrialseptaldefectinapatientwithseverepulmonaryarterialhypertensionafter1yearuseofanoralendothelinreceptorantagonist

Ejemplares similares